Biopharmaceutical firm Attralus has completed a $25 million Series A financing designed to further validate its AT-01 pan-amyloid radiotracer for PET/CT.
Not only can different lung diseases look much the same in chest imaging, but distinct diagnoses may present widely dissimilar image patterns in the same patient at the same timepoint, too.
SIR said that this is its first official clinical practice guidelines, developed using best practice methodologies from the National Academy of Medicine.
Individuals felt safer at home with less interference to their normal everyday life, which helped them stay calm during the process, experts explained in Radiography.